| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 75, 721-725, Copyright © 1992 by Endocrine Society
ARTICLES |
H Masaki, M Nishikawa, M Urakami, M Yoshimura, N Toyoda, Y Mori, N Yoshikawa and M Inada
Second Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
To clarify further the activity of rT3, we examined the effect of rT3 on collagen-induced platelet activation as reflected by aggregation, serotonin release, and protein phosphorylation. rT3, T4, T3, and triiodothyroacetic acid inhibited collagen-induced platelet aggregation and serotonin release from platelets in a dose-dependent manner. However, thyronine did not inhibit collagen-induced platelet aggregation. The concentration at which rT3 inhibited by 50% collagen- induced platelet aggregation was 30 +/- 4 (mean +/- SE) mumol/L. rT3, T4, and T3 did not differ significantly in their abilities to inhibit platelet aggregation. Moreover, rT3 inhibited collagen-induced phosphorylation of the 20-kilodalton protein (myosin light chain) in platelets. In contrast, rT3 did not inhibit 12-O-tetradecanoylphorbol 13-acetate (TPA)- or thrombin-induced platelet aggregation and inhibited only minimally TPA-induced 40-kilodalton protein phosphorylation. These results suggest that rT3 inhibits collagen- induced platelet activation by inhibiting the activity of myosin light chain kinase and that it may be interesting to investigate some kinds of activity of rT3.
This article has been cited by other articles:
![]() |
S. Taddei, N. Caraccio, A. Virdis, A. Dardano, D. Versari, L. Ghiadoni, A. Salvetti, E. Ferrannini, and F. Monzani Impaired Endothelium-Dependent Vasodilatation in Subclinical Hypothyroidism: Beneficial Effect of Levothyroxine Therapy J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3731 - 3737. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Lien, B. G. Nedrebø, J. E. Varhaug, O. Nygård, A. Aakvaag, and P. M. Ueland Plasma Total Homocysteine Levels during Short-Term Iatrogenic Hypothyroidism J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1049 - 1053. [Abstract] [Full Text] |
||||
![]() |
A. E. Hak, H. A.P. Pols, T. J. Visser, H. A. Drexhage, A. Hofman, and J. C.M. Witteman Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study Ann Intern Med, February 15, 2000; 132(4): 270 - 278. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |